Case Report on Isoniazid Induced Lupus Erythematosus: An Autoimmune Phenomenon

Authors

  • Bathala Anitha Swathi College of Pharmacy, NH5, Next to Nellore Toll Plaza, Venkatachallam, SPSR Nellore– 524 320, Andhra Pradesh, India
  • Katta Sridhar Swathi College of Pharmacy, NH5, Next to Nellore Toll Plaza, Venkatachallam, SPSR Nellore– 524 320, Andhra Pradesh, India
  • Madhavi Latha C Swathi College of Pharmacy, NH5, Next to Nellore Toll Plaza, Venkatachallam, SPSR Nellore– 524 320, Andhra Pradesh, India

DOI:

https://doi.org/10.26452/fjphs.v1i1.4

Keywords:

Drug-Induced Lupus (DIL), Systemic Lupus Erythematosus (SLE), Isoniazid, Antinuclear antibodies, Anti medication therapy

Abstract

Drug-Induced Lupus is an autoimmune disorder (DIL) sharing similarity with Systemic Lupus Erythematosus (SLE) which is characterized by the production of autoantibodies. DIL is a little different phenomenon where a drug exposure leads to the development of SLE and the symptoms are usually resolved with the discontinuation of the offending agent. A Tuberculosis Patient was consulted the physician with chief complaints of fever and skin rash associated with erythema since 4 days. He is on Anti TB medication therapy (RIPES) since 6 months. After the detailed investigations, it is found that antinuclear antibodies were elevated and seemed to be Lupus. Isoniazid was suspected as a culprit drug in this case with supporting references. De-challenging of Isoniazid improves the patient health and resolved from the symptoms of SLE.

Downloads

Download data is not yet available.

Published

2021-01-18 — Updated on 2022-02-24

Versions

How to Cite

Bathala Anitha, Katta Sridhar, & Madhavi Latha C. (2022). Case Report on Isoniazid Induced Lupus Erythematosus: An Autoimmune Phenomenon. Future Journal of Pharmaceuticals and Health Sciences, 1(1), 21–23. https://doi.org/10.26452/fjphs.v1i1.4 (Original work published January 18, 2021)

Issue

Section

Case Report